Latest Ratios: P/E Ratio 15.9x · EV/EBITDA 7.7x · ROE 9.1%. (1996–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $36.1B | $30.0B | $22.1B | $28.0B | $39.4B | $43.0B | $27.4B | $27.9B | $29.4B | — | — |
| Enterprise Value | $48.3B | $42.3B | $34.1B | $39.6B | $50.5B | $53.3B | $37.3B | $38.4B | $36.3B | — | — |
| P/E Ratio → | 15.85 | 13.02 | 32.90 | 22.26 | 5.36 | 13.75 | 56.66 | 27.53 | 8.22 | — | — |
| P/S Ratio | 1.34 | 1.12 | 0.85 | 0.96 | 1.04 | 1.55 | 1.31 | 1.39 | 1.50 | — | — |
| P/B Ratio | 1.44 | 1.19 | 0.91 | 1.11 | 1.52 | 1.81 | 1.22 | 1.22 | 1.20 | — | — |
| P/FCF | 17.70 | 14.74 | 16.02 | 11.35 | 7.00 | 21.46 | 15.47 | 15.75 | 53.89 | — | — |
| P/OCF | 8.85 | 7.36 | 6.26 | 5.53 | 4.86 | 11.06 | 8.26 | 7.62 | 14.31 | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.57 | 1.31 | 1.36 | 1.33 | 1.92 | 1.79 | 1.91 | 1.85 | — | — |
| EV / EBITDA | 7.74 | 6.77 | 6.44 | 6.57 | 3.94 | 7.92 | 12.92 | 10.48 | 18.09 | — | — |
| EV / EBIT | 12.48 | 11.19 | 18.19 | 14.59 | 4.69 | 11.51 | 41.35 | 20.55 | 84.17 | — | — |
| EV / FCF | — | 20.75 | 24.68 | 16.07 | 8.96 | 26.63 | 21.05 | 21.63 | 66.57 | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 31.0% | 31.0% | 29.0% | 29.2% | 40.7% | 34.0% | 25.1% | 27.4% | 27.5% | 15.3% | 18.6% |
| Operating Margin | 14.4% | 14.4% | 11.4% | 13.3% | 28.5% | 17.3% | 4.3% | 9.3% | 2.1% | 4.6% | 10.3% |
| Net Profit Margin | 8.4% | 8.4% | 2.6% | 4.3% | 20.2% | 11.4% | 2.2% | 4.9% | 18.2% | 7.2% | 7.5% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 9.1% | 9.1% | 2.7% | 4.9% | 30.9% | 13.7% | 2.0% | 4.2% | 21.8% | 4.0% | 4.0% |
| ROA | 4.4% | 4.4% | 1.3% | 2.3% | 14.7% | 6.5% | 1.0% | 2.1% | 11.4% | 1.9% | 1.9% |
| ROIC | 7.8% | 7.8% | 6.0% | 7.9% | 22.9% | 10.8% | 2.1% | 4.3% | 1.4% | 1.2% | 2.7% |
| ROCE | 9.6% | 9.6% | 7.3% | 9.5% | 27.8% | 12.5% | 2.4% | 5.0% | 1.6% | 1.3% | 2.9% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.51 | 0.51 | 0.52 | 0.50 | 0.46 | 0.46 | 0.51 | 0.49 | 0.38 | 0.53 | 0.56 |
| Debt / EBITDA | 2.07 | 2.07 | 2.42 | 2.08 | 0.93 | 1.61 | 3.93 | 3.03 | 4.60 | 4.93 | 3.98 |
| Net Debt / Equity | — | 0.48 | 0.49 | 0.46 | 0.43 | 0.44 | 0.44 | 0.46 | 0.28 | 0.52 | 0.56 |
| Net Debt / EBITDA | 1.96 | 1.96 | 2.26 | 1.93 | 0.86 | 1.54 | 3.43 | 2.85 | 3.44 | 4.80 | 3.95 |
| Debt / FCF | — | 6.01 | 8.66 | 4.71 | 1.96 | 5.17 | 5.58 | 5.88 | 12.68 | 7.53 | 12.42 |
| Interest Coverage | 5.18 | 5.18 | 2.83 | 3.38 | 20.35 | 9.75 | 1.73 | 3.34 | 0.78 | 0.88 | 2.11 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.34 | 1.34 | 1.15 | 1.17 | 1.14 | 1.11 | 1.35 | 1.17 | 1.40 | 2.07 | 0.82 |
| Quick Ratio | 0.70 | 0.70 | 0.63 | 0.65 | 0.61 | 0.60 | 0.77 | 0.62 | 0.81 | 1.58 | 0.37 |
| Cash Ratio | 0.06 | 0.06 | 0.07 | 0.08 | 0.06 | 0.04 | 0.17 | 0.07 | 0.28 | 0.07 | 0.02 |
| Asset Turnover | — | 0.51 | 0.50 | 0.55 | 0.69 | 0.55 | 0.44 | 0.43 | 0.43 | 0.27 | 0.26 |
| Inventory Turnover | 2.66 | 2.66 | 3.00 | 3.25 | 2.94 | 2.89 | 3.18 | 2.93 | 2.90 | 4.89 | 4.72 |
| Days Sales Outstanding | — | 76.91 | 75.75 | 58.64 | 53.92 | 61.97 | 52.70 | 55.38 | 51.04 | 31.31 | 34.98 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 3.0% | 3.6% | 4.8% | 3.7% | 2.6% | 2.4% | 3.8% | 3.7% | 3.2% | — | — |
| Payout Ratio | 47.6% | 47.6% | 157.3% | 82.0% | 13.5% | 33.1% | 224.4% | 103.0% | 26.6% | 100.9% | 240.8% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 6.3% | 7.7% | 3.0% | 4.5% | 18.6% | 7.3% | 1.8% | 3.6% | 12.2% | — | — |
| FCF Yield | 5.6% | 6.8% | 6.2% | 8.8% | 14.3% | 4.7% | 6.5% | 6.4% | 1.9% | — | — |
| Buyback Yield | 1.6% | 1.9% | 0.8% | 3.7% | 11.5% | 2.4% | 0.6% | 6.9% | 6.1% | — | — |
| Total Shareholder Yield | 4.5% | 5.5% | 5.6% | 7.4% | 14.1% | 4.8% | 4.3% | 10.6% | 9.4% | — | — |
| Shares Outstanding | — | $487M | $494M | $497M | $540M | $571M | $570M | $583M | $625M | $336M | $336M |
Includes 30+ ratios · 30 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying NTR stock.
Nutrien Ltd.'s current P/E ratio is 15.9x. The historical average is 22.5x. This places it at the 50th percentile of its historical range.
Nutrien Ltd.'s current EV/EBITDA is 7.7x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 9.1x.
Nutrien Ltd.'s return on equity (ROE) is 9.1%. The historical average is 15.0%.
Based on historical data, Nutrien Ltd. is trading at a P/E of 15.9x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Nutrien Ltd.'s current dividend yield is 2.95% with a payout ratio of 47.6%.
Nutrien Ltd. has 31.0% gross margin and 14.4% operating margin. Operating margin between 10-20% is typical for established companies.
Nutrien Ltd.'s Debt/EBITDA ratio is 2.1x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.
Key Metrics
Top Statement Risk
Cyclical profitability masking core earnings
Cheap Valuation Amid Cyclical Recovery
Nutrien trades at a forward P/E of 13.15 and a PEG of 0.37, suggesting the market is pricing in significant earnings growth from the cyclical trough, though this may partially reflect the sector's inherent volatility rather than a deep value dislocation.
The valuation multiples, particularly the PEG of 0.37, imply a significant earnings rebound is anticipated. However, comparing to peers like CF Industries (PEG 0.33), Nutrien's discount is modest, suggesting the market is assigning a similar recovery multiple. The EV/EBITDA of 7.39 is below its own 10-quarter median, but this metric can be distorted during cyclical troughs when EBITDA is compressed, making the valuation appear artificially cheap relative to normalized earnings power.
Profitability Swings with Agricultural Seasonality
Operating margins expanded sharply to 18.4% in Q2 2026 from 8.4% in the prior quarter, a pattern consistent with Nutrien's highly seasonal business where profitability is concentrated in the spring application season.
The gross margin of 30.1% in Q2 2026 is near the high end of the recent range, indicating strong pricing or cost control during peak demand. However, the net margin of 11.2% demonstrates that a significant portion of gross profit is consumed by fixed operating costs, as evidenced by the relatively stable SG&A noted in prior analysis. This volatility means a single quarter's profitability is not indicative of the company's full-year earning power, which appears to be moderately resilient on a cycle-adjusted basis.
Capital Returns Cyclical, Not Compounding
ROIC surged to 3.9% in Q2 2026 from just 1.0% in Q1, but this remains below the threshold needed to consistently create shareholder value, indicating capital allocation is driven by commodity cycles rather than structural efficiency gains.
The ROIC trend is highly volatile, swinging from near-zero to mid-single digits within quarters, which is characteristic of a capital-intensive, commodity-driven business. The current ROIC of 3.9% is likely still below Nutrien's cost of capital, suggesting that on a quarterly basis, the company may not be generating economic profit. The drivers are clearly cyclical margin expansion rather than sustained improvements in asset turnover, which remains low at 0.20, reinforcing the capital-intensive nature of the operations.
Working Capital Drain is a Core Feature
Days Inventory Outstanding of 90 in Q2 2026 and a frequently erratic Cash Conversion Cycle underscore that significant capital is locked in the operational cycle, a key determinant of the company's volatile free cash flow.
The CCC data is inconsistent, with some periods missing, but when available it shows a wide range from 31 to over 100 days, indicating profound variability in working capital efficiency. The consistently high DIO reflects the need to carry inventory through seasonal cycles. The lack of a stable DPO figure (with many periods blank) suggests either data unavailability or highly variable payment terms with suppliers, making it difficult to assess true supplier leverage. This working capital volatility is a primary driver of the erratic free cash flow profile noted previously.
Seasonal Liquidity Pressures Evident
The current ratio of 1.39 and quick ratio of 0.86 in Q2 2026 indicate adequate headline liquidity, but the quick ratio below 1.0 highlights a material dependence on inventory sales to meet short-term obligations.
The gap between the current and quick ratios has persisted at around 0.53 over the last two quarters, quantifying the inventory-heavy nature of Nutrien's working capital. This structure creates seasonal vulnerability; in periods of weak sales or falling commodity prices, converting inventory to cash could become challenging. The cash balance of $921M provides a buffer, but the liquidity position is not fortress-like and would likely deteriorate under a severe, sustained downturn in the agricultural cycle.
The Peril of Cyclically-Adjusted P/E
The most commonly misapplied ratio is the P/E ratio, as the trailing 15.37 appears reasonable but is based on earnings that are recovering from depressed levels, potentially masking the true cyclical volatility of Nutrien's earnings stream.
Investors often use P/E to assess Nutrien, but this ratio is highly misleading without adjustment. The low P/E of 15.37 is calculated on earnings that surged 18.5% in Q1 2026, but this growth follows a -93.0% decline in Q1 2025, making the metric highly sensitive to the trough of the cycle. A more appropriate metric would be a price-to-peak-earnings or a mid-cycle earnings multiple, which would likely show a higher valuation. Relying on the simple P/E risks underappreciating the magnitude of earnings volatility and overestimating the sustainability of the current earnings level.